We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Afqlir; Enzeevu

Australian Public Assessment Report

AusPAR

AusPAR Afqlir; Enzeevu [PDF, 858.16 KB]

AusPAR Afqlir; Enzeevu [DOCX, 789.09 KB]

Attachment Product information for Afqlir [PDF, 2.11 MB]

Attachment Product information for Afqlir [DOCX, 1.63 MB]

Attachment Product information for Enzeevu [PDF, 1.04 MB]

Attachment Product information for Enzeevu [DOCX, 1.62 MB]

Device/Product Name

Afqlir; Enzeevu

Active ingredients

Aflibercept

AusPAR Date

29 October 2025

Published

12 November 2025

Submission Number

PM-2024-01570-1-5

Submission Type

New biosimilar entity

Decision

Approved

Product types

Prescription medicines